Nattokinase and blood pressure

What 3 graded rows on nattokinase agree on for blood pressure, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Nattokinase page, with its PubMed record.

Your question

Nattokinase and blood pressure

3 rows · 711 people

Mostly an improvement: 2 of 3 rows, and most of the people. 1 had mixed results.

Mixed
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside. Outlined: mixed results.
  • Grade C× 2
  • Grade D× 1
Rows
3
Trials
8
People
711
Pooled reviews may count some twice

What the rows share

From the rows

The best-graded row, grade C, is a meta-analysis of 546 people (2023) and reported mixed results.

The rows run from 79 to 546 people, published from 2008 to 2023: 1 pooled review and 2 single studies.

The rows

2 improved · 1 mixed
  1. Grade CBlood pressure in prehypertension or stage 1 hypertension · Improved

    RCT · n 86 · 2008 · Adults 20–80 with untreated systolic BP 130–159 mmHg

    2,000 FU/day · 8 weeks

    Net changes versus placebo were −5.55 mmHg systolic and −2.84 mmHg diastolic (both p<0.05); plasma renin activity also fell.

    Row on the Nattokinase page · PubMed 18971533 (opens PubMed)

  2. Grade DBlood pressure in a North American hypertensive population · Improved

    RCT · n 79 · 2016 · Adults with systolic BP ≥130 or diastolic ≥90 mmHg (North America)

    100 mg/day · 8 weeks

    Diastolic BP fell from 87 to 84 mmHg versus no change on placebo (p<0.05), with larger drops in men; systolic reductions were reported for both sexes.

    Row on the Nattokinase page · PubMed 27785095 (opens PubMed)

  3. Grade CBlood pressure, lipids and glucose · Mixed

    Meta-analysis, 6 studies · n 546 · 2023 · Adults in 6 RCTs

    Varied across trials · Varied across trials

    Systolic BP fell 3.45 mmHg and diastolic 2.32 mmHg versus placebo, but total and LDL cholesterol rose slightly at lower doses and blood glucose rose 0.40 units; HDL fell at lower doses. No notable adverse events.

    Row on the Nattokinase page · PubMed 39076715 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.